AI-Designed drug targets scarred lungs in major trial

NCT ID NCT07687459

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether the oral drug rentosertib (INS018_055) can slow lung function decline in adults with idiopathic pulmonary fibrosis (IPF), a progressive lung disease. About 320 participants will receive either rentosertib or a placebo daily for 52 weeks. The main goal is to measure changes in forced vital capacity, a key indicator of lung health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
rentosertib (INS018_055)
What this could lead to
If successful, rentosertib could slow lung function decline in people with idiopathic pulmonary fibrosis, offering a new treatment option for this serious disease.
What could go wrong
This is a phase 3 trial, but results may not show benefit over placebo. The drug could have side effects, and its long-term safety is still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hangzhou First People's Hospital,School of Medicine, Westlake University

    Hangzhou, Zhejiang, China

  • Anhui Chest Hospital

    Hefei, Anhui, China

  • Anhui Provincial Hospital

    Hefei, Anhui, China

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Fuzhou University Affiliated Provincial Hospital

    Fuzhou, Fujian, China

  • Hainan General Hospital

    Haikou, Hainan, China

  • Hebei Medical University Third Hospital

    Shijiazhuang, Hebei, China

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China

  • Introduction of the First Affiliated Hospital of Shandong First Medical University

    Jinan, Shandong, China

  • Jiangxi Provincial People' Hospital

    Nanchang, Jiangxi, China

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China

  • Nanyang First People's Hospital

    Nanyang, Henan, China

  • Ningbo Medical Center Lihuili Hospital

    Ningbo, Zhejiang, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China

  • Shanghai Pulmonary Hospital Affiliated to Tongji University

    Shanghai, Shanghai Municipality, China

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • Sir Run Run Shaw Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital of Ningbo University

    Ningbo, Zhejiang, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

  • The First Affiliated Hospital of Xi'an Medical College

    Xi'an, Shaanxi, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • The First Hospital of Jiaxing

    Jiaxing, Zhejiang, China

  • The First People Hospital of Yunnan Province

    Kunming, Yunnan, China

  • The People's Hospital of Anyang City

    Anyang, Henan, China

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • The Second Affiliated Hospital of Xiamen Medical College

    Xiamen, Fujian, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • The Second Hospital of Jilin University

    Changchun, Jilin, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • The Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Tianjin Chest Hospital

    Tianjin, Tianjin Municipality, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China

  • Yichang Central People's Hospital

    Yichang, Hubei, China

  • Yuncheng Central Hospital

    Yuncheng, Shanxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.